Market Price

70.44 

-0.75 -1.1%

as of May 12 '21

52 Week Range:

42.85 73.81


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. Its spine product portfolio includes a range of implant and surgical approach options that could be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers imaging, navigation, and robotic assisted surgery technology solutions, as well as motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures. In addition, it provides regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. Further, the company offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems. Additionally, it distributes human cell, tissue, and cellular and tissue based products. The company sells its implants and related disposables primarily to hospitals through direct sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 0.95
3.89
4.23
4.80
5.85
7.07
8.44
9.68
11.58
13.41
14.21
growth rate 309.5% 8.7% 13.5% 21.9% 20.9% 19.4% 14.7% 19.6% 15.8% 6.0%
Earnings BIT 87.74
96.95
114.65
102.00
143.09
164.31
163.12
166.64
176.88
176.75
115.47
growth rate 10.5% 18.3% -11.0% 40.3% 14.8% -0.7% 2.2% 6.2% -0.1% -34.7%
Avg.PE 13.11
27.70
25.03
21.70
26.96
43.99
37.82
35.87
35.87
growth rate 111.3% -9.6% -13.3% 24.2% 63.2% -14.0% -5.2% 0.0%
ROA 20.43
20.40
19.02
13.54
14.57
14.67
11.85
10.70
13.15
10.96
6.37
growth rate -0.2% -6.8% -28.8% 7.6% 0.7% -19.2% -9.7% 22.9% -16.7% -41.9%
ROE 23.87
23.81
22.07
15.98
17.49
17.34
13.49
11.93
14.53
11.99
7.03
growth rate -0.3% -7.3% -27.6% 9.5% -0.9% -22.2% -11.6% 21.8% -17.5% -41.4%
ROIC 23.33
23.81
22.07
15.98
17.38
17.21
13.22
11.46
13.51
10.90
7.03
growth rate 2.1% -7.3% -27.6% 8.8% -1.0% -23.2% -13.3% 17.9% -19.3% -35.5%
Cur. Ratio 6.90
8.84
9.11
6.13
5.26
6.59
6.43
6.67
6.56
6.17
6.80
growth rate 28.1% 3.1% -32.7% -14.2% 25.3% -2.4% 3.7% -1.7% -6.0% 10.2%
Quick Ratio 5.05
6.58
6.86
4.48
3.47
4.44
4.83
5.38
5.04
4.25
4.76
growth rate 30.3% 4.3% -34.7% -22.5% 28.0% 8.8% 11.4% -6.3% -15.7% 12.0%
Leverage 1.17
1.17
1.16
1.20
1.20
1.16
1.11
1.11
1.10
1.09
1.11
growth rate 0.0% -0.9% 3.5% 0.0% -3.3% -4.3% 0.0% -0.9% -0.9% 1.8%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 42.43
66.22
82.38
102.45
81.20
86.35
95.78
127.06
144.36
162.42
148.10
growth rate 56.1% 24.4% 24.4% -20.7% 6.3% 10.9% 32.7% 13.6% 12.5% -8.8%
Acct.Payable 28.07
38.07
66.21
21.26
15.97
17.47
25.04
25.90
24.61
18.21
growth rate 35.6% 73.9% -67.9% -24.9% 9.4% 43.3% 3.4% -5.0% -26.0%
Cur.Assets 218.97
258.78
360.11
416.81
470.03
544.80
513.77
620.34
630.68
687.47
821.77
growth rate 18.2% 39.2% 15.7% 12.8% 15.9% -5.7% 20.7% 1.7% 9.0% 19.5%
Total Assets 266.58
329.39
447.13
566.30
703.55
834.10
927.64
1,078.50
1,300.67
1,532.08
1,679.49
growth rate 23.6% 35.8% 26.7% 24.2% 18.6% 11.2% 16.3% 20.6% 17.8% 9.6%
Cash 111.70
142.67
212.40
89.96
82.27
60.15
66.95
118.82
139.65
195.72
239.40
growth rate 27.7% 48.9% -57.7% -8.6% -26.9% 11.3% 77.5% 17.5% 40.2% 22.3%
Inventory 40.88
47.37
62.31
70.35
90.95
105.26
112.69
108.41
131.25
196.31
229.15
growth rate 15.9% 31.5% 12.9% 29.3% 15.7% 7.1% -3.8% 21.1% 49.6% 16.7%
Cur.Liabilities 31.73
29.27
39.51
67.94
89.41
82.69
79.89
93.07
96.12
111.40
120.79
growth rate -7.8% 35.0% 72.0% 31.6% -7.5% -3.4% 16.5% 3.3% 15.9% 8.4%
Liabilities 38.38
46.91
60.63
93.94
118.09
118.78
95.56
110.72
115.15
129.63
173.19
growth rate 22.2% 29.2% 54.9% 25.7% 0.6% -19.6% 15.9% 4.0% 12.6% 33.6%
LT Debt 0.00 0.00 0.00
growth rate
Equity 228.20
282.48
386.50
472.36
585.45
715.32
832.08
967.78
1,185.52
1,402.45
1,506.30
growth rate 23.8% 36.8% 22.2% 23.9% 22.2% 16.3% 16.3% 22.5% 18.3% 7.4%
Common Shares 75.00
75.00
92.00
94.00
95.00
96.00
96.00
98.00
101.00
102.00
101.00
growth rate 0.0% 22.7% 2.2% 1.1% 1.1% 0.0% 2.1% 3.1% 1.0% -1.0%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 12.30
22.49
24.68
23.68
24.75
50.76
40.91
51.30
59.70
70.75
63.66
growth rate 82.8% 9.8% -4.1% 4.5% 105.1% -19.4% 25.4% 16.4% 18.5% -10.0%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA 71.30
76.41
76.52
93.47
79.17
124.01
147.82
159.06
181.64
171.98
198.79
growth rate 7.2% 0.1% 22.2% -15.3% 56.6% 19.2% 7.6% 14.2% -5.3% 15.6%
FCF per Share 0.59
0.56
0.63
0.94
0.36
1.28
1.16
1.25
0.88
1.06
growth rate -5.1% 12.5% 49.2% -61.7% 255.6% -9.4% 7.8% -29.6% 20.5%
Sale Purchase of Stock -9.14
22.46
7.56
9.74
5.48
5.87
11.74
growth rate 100.0% -66.4% 28.9% -43.8% 7.3% 99.8%
FCF 59.00
54.00
52.00
70.00
54.00
71.00
131.00
108.00
122.00
101.00
135.00
growth rate -8.5% -3.7% 34.6% -22.9% 31.5% 84.5% -17.6% 13.0% -17.2% 33.7%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 288.20
331.48
385.99
434.46
467.27
536.65
563.99
635.98
712.97
785.37
789.04
growth rate 15.0% 16.5% 12.6% 7.6% 14.9% 5.1% 12.8% 12.1% 10.2% 0.5%
Op.Income 87.70
60.78
73.83
68.61
143.09
164.31
163.12
166.64
176.88
176.75
115.47
growth rate -30.7% 21.5% -7.1% 108.6% 14.8% -0.7% 2.2% 6.2% -0.1% -34.7%
IBT 87.70
96.95
114.65
102.00
138.64
172.81
157.28
169.93
188.61
189.95
125.90
growth rate 10.6% 18.3% -11.0% 35.9% 24.6% -9.0% 8.0% 11.0% 0.7% -33.7%
Net Income 54.50
60.78
73.83
68.61
92.49
112.78
104.34
107.35
156.47
155.21
102.29
growth rate 11.5% 21.5% -7.1% 34.8% 22.0% -7.5% 2.9% 45.8% -0.8% -34.1%
EPS 0.72
0.81
0.80
0.73
0.97
1.17
1.08
1.10
1.54
1.52
1.01
growth rate 12.5% -1.2% -8.8% 32.9% 20.6% -7.7% 1.9% 40.0% -1.3% -33.6%
Gross Profit 234.40
262.68
310.80
334.12
363.60
412.42
429.29
485.52
553.56
605.39
571.58
growth rate 12.1% 18.3% 7.5% 8.8% 13.4% 4.1% 13.1% 14.0% 9.4% -5.6%
R&D 21.30
23.46
27.93
26.87
31.17
36.31
40.53
43.68
55.50
60.07
84.52
growth rate 10.2% 19.0% -3.8% 16.0% 16.5% 11.6% 7.8% 27.1% 8.3% 40.7%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 49.98
29.00
-25.31
51.28
60.51
growth rate -42.0% -100.0% 100.0% 18.0%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 162.42
138.68
136.07
151.37
148.10
growth rate -14.6% -1.9% 11.2% -2.2%
Acct.Payable 24.61
24.23
27.72
30.02
18.21
growth rate -1.6% 14.4% 8.3% -39.4%
Cur.Assets 687.47
641.80
696.89
811.95
821.77
growth rate -6.6% 8.6% 16.5% 1.2%
Total Assets 1,532.08
1,479.37
1,465.80
1,541.74
1,679.49
growth rate -3.4% -0.9% 5.2% 8.9%
Cash 195.47
166.74
165.55
250.61
239.40
growth rate -14.7% -0.7% 51.4% -4.5%
Inventory 196.31
208.45
224.46
231.86
229.15
growth rate 6.2% 7.7% 3.3% -1.2%
Cur.Liabilities 111.40
97.96
106.13
99.98
120.79
growth rate -12.1% 8.3% -5.8% 20.8%
Liabilities 129.63
116.00
128.89
124.54
173.19
growth rate -10.5% 11.1% -3.4% 39.1%
LT Debt
growth rate
Equity 1,402.45
1,363.37
1,336.92
1,417.20
1,506.30
growth rate -2.8% -1.9% 6.0% 6.3%
Common Shares 99.83
0.10
0.10
0.10
0.10
growth rate -99.9% -1.0% 1.0% 1.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 15.79
22.31
9.96
17.33
14.06
growth rate 41.3% -55.4% 74.0% -18.8%
Cash Dividends
growth rate
Cash From OA 54.31
42.29
23.07
53.25
80.18
growth rate -22.1% -45.5% 130.8% 50.6%
Sale Purchase of Stock
growth rate
FCF 38.52
19.98
13.11
35.92
66.12
growth rate -48.1% -34.4% 174.0% 84.1%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 211.67
190.58
148.92
216.10
233.45
growth rate -10.0% -21.9% 45.1% 8.0%
Op.Income 49.98
29.00
-25.31
51.28
60.51
growth rate -42.0% -100.0% 100.0% 18.0%
IBT 54.45
32.50
-21.94
53.13
62.21
growth rate -40.3% -100.0% 100.0% 17.1%
Net Income 45.53
25.95
-20.84
44.22
52.96
growth rate -43.0% -100.0% 100.0% 19.8%
EPS
growth rate
Gross Profit 162.91
141.71
98.28
159.00
172.59
growth rate -13.0% -30.7% 61.8% 8.5%
R&D 15.50
15.40
39.46
14.42
15.24
growth rate -0.6% 156.2% -63.5% 5.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (61.79)

YOY Growth Grade:

C (57.50)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 35.87 50.31 26.29
EPS / Growth 10.2% 1.40 11.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.2% 12.7% 12.7%
Future PE 20.30 29.17 29.17
Future EPS 3.68 4.62 4.62
Value Price
MOS %
18.47
-73.8%
33.28
-52.8%
33.28
-52.8%
MOS Price 9.24 16.64 16.64
IRT 17.88 15.89 15.89

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.